Business
WHO Foundation and Novo Nordisk Expand Collaboration to Provide Financial Support towards strengthening health systems for Cardio-Renal-Metabolic Diseases
The WHO Foundation today announced an expanded collaboration with Novo Nordisk to support global efforts to strengthen health systems against the rising burden of cardio-renal-metabolic diseases, including obesity and diabetes.
About this update from Novo Nordisk A/s Class B
[{"type":"text","content":"GENEVA, March 11, 2026 /PRNewswire/ -- The WHO Foundation today announced an expanded collaboration with Novo Nordisk to support global efforts to strengthen health systems against the rising burden of cardio-renal-metabolic diseases, including obesity and diabetes.","length":271,"tagName":"p"},{"type":"image","alt":"Representatives from the WHO Foundation, Novo Nordisk, and health partners gathered at the launch of the Roadmap for Promoting Health and Addressing Childhood Obesity in School Settings under the Shine India initiative, marking a collaborative step toward preventing childhood obesity and promoting healthier school environments in India.","displaySize":"","headline":null,"caption":"Representatives from the WHO Foundation, Novo Nordisk, and health partners gathered at the launch of the Roadmap for Promoting Health and Addressing Childhood Obesity in School Settings under the Shine India initiative, marking a collaborative step toward preventing childhood obesity and promoting healthier school environments in India.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/bafcc9f14083e6ba946132ed87d26829"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/56f2qVm8BcsZDZPAm2NNVw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/bafcc9f14083e6ba946132ed87d26829","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/2931415/WHO_Foundation.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Novo Nordisk has committed a total of USD 7.9 million to support this effort, with an initial gift of USD 2.9 million in 2024 followed by an additional USD 5 million in December 2025.","length":183,"tagName":"p"},{"type":"text","content":"The contribution will enable the WHO Foundation to support WHO's broader efforts to address noncommunicable diseases through prevention, early action, and strengthened primary health care, particularly in low- and middle-income countries where health systems often face capacity constraints.","length":295,"tagName":"p"},{"type":"text","content":""Cardio-renal-metabolic diseases are complex conditions that demand prevention-first approaches anchored in strong and resilient health systems," said Anil Soni, Chief Executive Officer o...